Discovery of isoxazolyl-based inhibitors of cGMP-dependent protein kinase.

The cGMP-dependent protein kinase in (PfPKG) plays multiple roles in the life cycle of the parasite. As a result, this enzyme is a potential target for new antimalarial agents. Existing inhbitors, while potent and active in malaria models are not optimal.